<DOC>
	<DOC>NCT00621296</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.</brief_summary>
	<brief_title>Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<criteria>Patients diagnosed with genotype 1b chronic hepatitis C Patients naive to the concomitant medications with interferon Patients diagnosed with decompensated cirrhosis Patients diagnosed with positive HBs antigen in the test</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Protease Inhibitor</keyword>
</DOC>